January 21, 2015 | Before its anticipated NASDAQ IPO, the Israeli medical device company Check-Cap announced changes to its board of directors. The company, which has developed a non-invasive X-Ray pill for intestinal screening, hopes to raise $15 million in its IPO that was announced last week. The new members of the board include Yuval Yanai, the former CTO at Given Imaging, a Check-Cap competitor that was sold to the Irish company Covidien for almost $1 billion, and Steven J. Hanley, a former president at Covidien and CEO of MediBeacon. Check-Cap was founded in 2005 by Dr. Yoav Kimchy.
Subscribe to NoCamels weekly newsletter and get our top stories
Facebook comments